

[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI

[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
Matthew Harrison Maintained (SRPT) at Hold with Increased Target to $163 on, Jun 20th, 2018
Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Increased Target from $91 to $163 on, Jun 20th, 2018.
Matthew has made no other calls on SRPT in the last 4 months.
There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Hartaj Singh of "Oppenheimer" Downgraded from Buy to Hold on, Friday, May 4th, 2018
These are the ratings of the 5 analyists that currently disagree with Matthew
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $267 on, Tuesday, June 19th, 2018
- Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $120 on, Friday, June 15th, 2018
- Gena Wang of "Barclays" Upgraded from Hold to Buy on, Friday, May 11th, 2018
- Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $92 on, Friday, May 4th, 2018
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $95 on, Wednesday, March 14th, 2018
Contributing Sources